|
|
Substance Name: Onercept [USAN:INN]
RN: 199685-57-9
UNII: 1IEO802L3J
Note
- A recombinant human soluble p55 tumor necrosis factor binding protein for the treatment of a number of disorders, including Crohn's disease, psoriasis and psoriatic arthritis; TNFbp (pharmacologic) is the dimeric polyethylene glycol linked form of the type I soluble receptor of tumor necrosis factor (TNF) that acts as a TNF inhibitor.
Molecular Formula
- C753-H1156-N228-O247-S25
Molecular Weight
- 18156.4144
Classification Codes
- Anti-TNF (Tumor Necrosis Factor) Activity
- TNF Binding Proteins
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Onercept [USAN:INN]
Synonyms
- Glycoprotein TNF-BP (tumor necrosis factor-binding protein) (human disulfide variant 1). Molecular weight is approximately 18,000 daltons
- Glycoprotein TNF-BP (tumor necrosis factor-binding protein) (human disulfide varinat 1)
- Human soluble TNF p55 receptor
- Onercept
- r-hTBP-1
- Recombinant human soluble p55 tumor necrosis factor binding protein
- Recombinant human soluble p55 tumour necrosis factor receptor
- UNII-1IEO802L3J
Registry Numbers
CAS Registry Number
- 199685-57-9
FDA UNII
- 1IEO802L3J
System Generated Number
- 0199685579